Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,004 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of strategies for vascular ACCESS closure after transcatheter aortic valve implantation: the ACCESS-TAVI randomized trial.
Rheude T, Ruge H, Altaner N, Pellegrini C, Alvarez Covarrubias H, Mayr NP, Cassese S, Kufner S, Taniguchi Y, Thilo C, Klos M, Erlebach M, Schneider S, Jurisic M, Laugwitz KL, Lange R, Schunkert H, Kastrati A, Krane M, Xhepa E, Joner M. Rheude T, et al. Among authors: kastrati a. Eur Heart J. 2024 Oct 29:ehae784. doi: 10.1093/eurheartj/ehae784. Online ahead of print. Eur Heart J. 2024. PMID: 39474906
Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trial.
Mehilli J, Ndrepepa G, Kastrati A, Neumann FJ, ten Berg J, Bruskina O, Dotzer F, Seyfarth M, Pache J, Kufner S, Dirschinger J, Berger PB, Schömig A. Mehilli J, et al. Among authors: kastrati a. Am Heart J. 2007 Jul;154(1):158.e1-7. doi: 10.1016/j.ahj.2007.03.050. Am Heart J. 2007. PMID: 17584569 Clinical Trial.
One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial.
Ndrepepa G, Kastrati A, Mehilli J, Neumann FJ, ten Berg J, Bruskina O, Dotzer F, Seyfarth M, Pache J, Dirschinger J, Berger PB, Schömig A. Ndrepepa G, et al. Among authors: kastrati a. Eur Heart J. 2008 Feb;29(4):455-61. doi: 10.1093/eurheartj/ehm562. Epub 2007 Dec 23. Eur Heart J. 2008. PMID: 18158289 Clinical Trial.
Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis.
Mehilli J, Byrne RA, Wieczorek A, Iijima R, Schulz S, Bruskina O, Pache J, Wessely R, Schömig A, Kastrati A; Intracoronary Stenting and Angiographic Restenosis Investigators--Test Efficacy of Rapamycin-eluting Stents with Different Polymer Coating Strategies (ISAR-TEST-3). Mehilli J, et al. Among authors: kastrati a. Eur Heart J. 2008 Aug;29(16):1975-82. doi: 10.1093/eurheartj/ehn253. Epub 2008 Jun 11. Eur Heart J. 2008. PMID: 18550554 Clinical Trial.
Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial.
Byrne RA, Kastrati A, Kufner S, Massberg S, Birkmeier KA, Laugwitz KL, Schulz S, Pache J, Fusaro M, Seyfarth M, Schömig A, Mehilli J; Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Investigators. Byrne RA, et al. Among authors: kastrati a. Eur Heart J. 2009 Oct;30(20):2441-9. doi: 10.1093/eurheartj/ehp352. Epub 2009 Aug 30. Eur Heart J. 2009. PMID: 19720642 Clinical Trial.
1,004 results